Showing results (851-860 of 1,138) with videos related to
Sort By:
Pageof 114
Cancer Genetics|August 29, 2021
Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencingShravan Kumar Mishra, Niraj Kumari, Narendra Krishnani, et al.Cancer Genetics|May 24, 2015
Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinomaJi Wook Moon, Jong-Ho Choi, Soo Kyung Lee, et al.Cancer Genetics|May 13, 2015
ARID1A and TERT promoter mutations in dedifferentiated meningiomaMalak S Abedalthagafi, Wenya Linda Bi, Parker H Merrill, et al.Cancer Genetics|June 3, 2015
Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalitiesDandan Liu, Yong Zhang, Suning Chen, et al.Cancer Genetics|May 17, 2015
Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancerCristina Iobagiu, Claude Lambert, Marius Raica, et al.Cancer Genetics|May 16, 2015
Single nucleotide polymorphisms of the NF-κB and STAT3 signaling pathway genes predict lung cancer prognosis in a Chinese Han populationFei He, Rong Yang, Xiao-yu Li, et al.Cancer Genetics|October 23, 2019
Progress in quantitative technique of circulating cell free DNA and its role in cancer diagnosis and prognosisJia-Lei Weng, Manar Atyah, Chen-Hao Zhou, et al.Cancer Genetics|October 27, 2019
Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumoursFiroz Ahmad, Purva Surve, Sripriya Natarajan, et al.Cancer Genetics|December 18, 2021
Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patientsMeryem El Azzouzi, Hajar El Ahanidi, Chaimae Hafidi Alaoui, et al.Cancer Genetics|January 10, 2022
Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testingAnne Koehne de González, Mahesh M Mansukhani, Helen Fernandes, et al.Pageof 114